Several months ago the FDA warned that SGLT2 inhibitors like Invokana may cause diabetic ketoacidosis, a condition that occurs when there is…
Guidelines are mixed but generally have recommended systolic pressure be up to 130 in patients who also diabetes.
New research suggests that half of all U.S. adults have diabetes or pre-diabetes.
The study of government health surveys echoes previous research and shows numbers increased substantially between 1988 and 2012 although they mostly leveled off after 2008. Overall, 12 percent to 14 percent of adults had diagnosed diabetes in 2012, the latest data available. Most of that is Type 2 diabetes, the kind linked with obesity and inactivity.
The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced today that the first…
The U.S. FDA has approved Tandem’s t:slim G4 insulin pump. The t:slim G4 combines features of the t:slim Insulin Pump and Dexcom's G4 PLATINUM CGM System into a single device that is simple to use. The t:slim G4 insulin pump is the only pump that conveniently displays CGM graphs and trend information with current insulin delivery activity together on the home screen to help make informed treatment decisions. Orders for the t:slim G4 Insulin Pump can be placed now with shipments expected to begin in October 2015.
Sanofi and the Google life sciences team announced that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes. The collaboration will pair Sanofi's leadership in diabetes treatments and devices with Google's expertise in analytics, miniaturized electronics and low power chip design.
Insulet Corporation (Insulet or the Company) has initiated a lot-specific voluntary recall of 40,846 boxes (10 Pods per box) of the OmniPod (Pod)…
The U.S. Food and Drug Administration (FDA) has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System. With wireless Bluetooth technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver.
Stepping back into those old parenting habits when your child already lives on their own and does just fine can ruin a perfectly wonderful visit or summer stay. So, what’s a parent to do? I am hoping by thinking it out ahead of time and making myself aware, I’ll avoid the pratfalls many of us face when our young adults come home.
Based on a thorough review of the scientific evidence, the U.S. Food and Drug Administration (FDA) today finalized its determination that partially hydrogenated oils (PHOs), the primary dietary source of artificial trans fat in processed foods, are not “generally recognized as safe” (GRAS) for use in food.